Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV interferon beta-1a (MR11A8) for moderate or severe ARDS
jRCT2080223265Phase 3Completed
- Sponsor
- Maruishi Pharmaceutical Co., Ltd.
- Start
- Jul 2016
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute respiratory distress syndrome (ARDS) comparing MR11A8 (interferon beta-1a) with Placebo (2 arms). Started Jul 2016; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on jRCT2080223265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223265.